Clinical Trials Browser

Phase 2 × Sarcoma × pegamotecan × Clear all

NCT00079950 2012-09-06

Efficacy and Safety Evaluation of Pegamotecan (PEG-camptothecin) in Advanced or Metastatic Soft Tissue Sarcoma

Phase 2 Suspended

Neoplasm Metastasis, Sarcoma